In recent trading days, Therapeutic Solutions International (OTCMKTS:TSOI) has come into significant focus among investors and that can be gauged from the price action in the stock. Yesterday, the stock continued to be in focus and ended up with gains of 12%. That took the gains made by the stock over the past week to as much as 24%.
Trading Data
On Monday, TSOI stock moved up 11.70% to $0.0258 with more than 9.66 million shares, compared to its average Monday of 6.06 million shares. The stock moved within a range of $0.0244 – 0.0284 after opening trade at $0.0244.
Therapeutic Solutions International Selects Premier Regenerative Medicine CRO Biorasi to Initiate and Run Phase III FDA Registration Clinical Trial for JadiCell™ Universal Donor Adult Stem Cell Product
Yesterday the company was in the news once again after it announced that Biorasi had been selected as the contract research organisation of Therapeutic Solutions by its Board of Directors. It was a major new announcement from the company and for good reason too.
Biorasi is going to be involved in the crucial FDA Registered Clinical Trial that is going to take place for the JadiCell Adult Stem Cell product from Therapeutic Solutions. The product is meant for those patients who may be suffering from advanced symptoms of COVID 19.
The selection of a contract research organisation is a sound first step from the company and it is clear to see that the development led to a certain degree of optimism among investors yesterday. It may be a good time to add the stock to your watch lists.
Key Quote
“The family of mesenchymal stem cells in general possess dual anti-inflammatory and regenerative properties, which make them a promising therapeutic for lung conditions. Based on published, and our independent studies, the JadiCell appears to be superior to other stem cells both in suppressing cytokine storm and activating endogenous pulmonary repair mechanisms,” said Dr. Thomas Ichim, Board Member of TSOI.
Technical Data
TSOI stock is trading above the 20-Day and 200-Day Moving averages of $0.0224 and $0.0023 respectively. However, the stock is trading below the 50-Day moving average of $0.0409.
